Gastroenterology.
Internal Medicine, School of Medicine, University of Hacettepe, Ankara, Turkey.
Surg Laparosc Endosc Percutan Tech. 2022 Dec 1;32(6):714-719. doi: 10.1097/SLE.0000000000001090.
During the COVID-19 pandemic, elective endoscopic retrograde cholangiopancreatography (ERCP) procedures have been postponed as recommended by international guidelines. In this study, the results of biliary and pancreatic ERCP procedures that had to be postponed during the pandemic process were investigated.
Forty-seven patients whose stent exchange procedures with ERCP were postponed between March 2020 and June 2020 due to the COVID-19 pandemic were included in the study. Patients were evaluated in 2 groups as delayed biliary procedures (n: 32) and delayed pancreatic procedures (n: 15). Clinical problems (biliary or pancreatic pain, itching, cholangitis, etc.) and technical problems encountered during the procedure (stent migration, abundant stone sludge in the bile ducts, etc.) were compared with 46 patients who could be treated without delay (39 interventions for the biliary system and seven interventions for the pancreas).
Considering the procedures for the biliary system, there was no difference in age and sex between the groups. Although clinical problems in biliary procedures were more common in the group with delay than in those without delay, this difference was not significant (34% vs. 20%; P : 0.14). The technical problems encountered during the procedures in the group with delay were significantly higher than those without delay (21% vs. 2.5%; P : 0.019), with stent migration being the most common problem (n: 5). Age and sex did not differ in the patients who had pancreatic interventions with and without delay. The clinical problems that developed in the patients did not differ between the groups with and without delay (26% vs. 28%; P : 0.8). Although technical problems were encountered in 1 out of 15 patients in the group with delay, no technical problem was experienced in the group without delay ( P : 0.68).
Postponing elective ERCP procedures for the biliary system not for the pancreatic system during the COVID-19 pandemic brings technical problems.
在 COVID-19 大流行期间，国际指南建议推迟择期内镜逆行胰胆管造影（ERCP）手术。在这项研究中，研究了在大流行期间不得不推迟的胆道和胰腺 ERCP 手术的结果。
47 名患者因 COVID-19 大流行而推迟 ERCP 支架更换术，将其纳入本研究。将患者分为两组，即延迟胆道手术组（n=32）和延迟胰腺手术组（n=15）。比较两组在手术过程中遇到的临床问题（胆道或胰腺疼痛、瘙痒、胆管炎等）和技术问题（支架迁移、胆管内大量结石碎片等），并与 46 名可及时治疗的患者进行比较（胆道系统 39 例干预，胰腺系统 7 例干预）。
考虑到胆道系统的手术，两组患者的年龄和性别无差异。尽管延迟组的胆道手术中临床问题更为常见，但差异无统计学意义（34%比 20%；P=0.14）。延迟组手术过程中遇到的技术问题明显高于无延迟组（21%比 2.5%；P=0.019），支架迁移是最常见的问题（n=5）。有延迟和无延迟胰腺介入治疗的患者年龄和性别无差异。两组患者的临床问题无差异（26%比 28%；P=0.8）。尽管延迟组的 1 名患者出现了技术问题，但无延迟组未出现技术问题（P=0.68）。
在 COVID-19 大流行期间，选择性 ERCP 手术对于胆道系统而非胰腺系统进行推迟会带来技术问题。
